Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stergios A Polyzos

Showing results (1-10 of 430) with videos related to

Pageof 43
Sort By:
The New England Journal of Medicine|October 16, 2024
Two Trials of Therapeutics for MASH with Liver FibrosisStergios A Polyzos
Current Medicinal Chemistry|August 11, 2012
Editorial: adiponectin in health and disease: current evidence and therapeutic perspectivesStergios A Polyzos
Minerva Endocrinologica|October 30, 2016
Endocrine and metabolic disorders interplaying with non-alcoholic fatty liver diseaseStergios A Polyzos
Clinical Rheumatology|November 6, 2010
Prolonged anti-resorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with Paget's disease of boneStergios A Polyzos
Journal of Clinical Gastroenterology|April 30, 2019
Helicobacter pylori Infection: One More Contributor to Nonalcoholic Fatty Liver Disease PathophysiologyStergios A Polyzos, Jannis Kountouras
Helicobacter|April 10, 2015
Novel Advances in the Association Between Helicobacter pylori Infection, Metabolic Syndrome, and Related MorbidityStergios A Polyzos, Jannis Kountouras
Inflammatory Bowel Diseases|September 18, 2014
Bone and fat interplay in inflammatory bowel disease: clinical implications and future perspectivesStergios A Polyzos, Jannis Kountouras
Current Vascular Pharmacology|February 9, 2023
Nonalcoholic Fatty Liver Disease and <i>Helicobacter pylori</i> Infection: Is it Time to Address this Potential Relationship?Stergios A Polyzos, Jannis Kountouras
Diabetes, Obesity & Metabolism|December 10, 2024
Hepatic thyroid hormone receptor-β signalling: Mechanisms and recent advancements in the treatment of metabolic dysfunction-associated steatohepatitisStergios A Polyzos, Giovanni Targher
Diabetes, Obesity & Metabolism|October 6, 2025
AdipoRon exerts divergent effects on hepatic and bone metabolismStergios A Polyzos, Jannis Kountouras
Pageof 43

Showing results (1-10 of 430) with videos related to

Sort By:
Pageof 43
The New England Journal of Medicine|October 16, 2024
Two Trials of Therapeutics for MASH with Liver FibrosisStergios A Polyzos
Current Medicinal Chemistry|August 11, 2012
Editorial: adiponectin in health and disease: current evidence and therapeutic perspectivesStergios A Polyzos
Minerva Endocrinologica|October 30, 2016
Endocrine and metabolic disorders interplaying with non-alcoholic fatty liver diseaseStergios A Polyzos
Clinical Rheumatology|November 6, 2010
Prolonged anti-resorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with Paget's disease of boneStergios A Polyzos
Journal of Clinical Gastroenterology|April 30, 2019
Helicobacter pylori Infection: One More Contributor to Nonalcoholic Fatty Liver Disease PathophysiologyStergios A Polyzos, Jannis Kountouras
Helicobacter|April 10, 2015
Novel Advances in the Association Between Helicobacter pylori Infection, Metabolic Syndrome, and Related MorbidityStergios A Polyzos, Jannis Kountouras
Inflammatory Bowel Diseases|September 18, 2014
Bone and fat interplay in inflammatory bowel disease: clinical implications and future perspectivesStergios A Polyzos, Jannis Kountouras
Current Vascular Pharmacology|February 9, 2023
Nonalcoholic Fatty Liver Disease and <i>Helicobacter pylori</i> Infection: Is it Time to Address this Potential Relationship?Stergios A Polyzos, Jannis Kountouras
Diabetes, Obesity & Metabolism|December 10, 2024
Hepatic thyroid hormone receptor-β signalling: Mechanisms and recent advancements in the treatment of metabolic dysfunction-associated steatohepatitisStergios A Polyzos, Giovanni Targher
Diabetes, Obesity & Metabolism|October 6, 2025
AdipoRon exerts divergent effects on hepatic and bone metabolismStergios A Polyzos, Jannis Kountouras
Pageof 43